Journal of Vaccine Research 2024, Vol.14, No.5, 217-230 http://medscipublisher.com/index.php/jvr 224 The development of multi-pathogen vaccines targeting both strains of the PRRS virus has been a focus of veterinary vaccine research. Current vaccines employ modified live virus (MLV) technology, offering protection against both strains, though efficacy can vary due to the genetic diversity of the virus. Newer approaches include vaccines that utilize viral vector platforms or inactivated virus formulations to provide broader protection against both PRRSV-1 and PRRSV-2. These vaccines have been shown to reduce viral shedding, improve survival rates, and limit transmission, with safety profiles comparable to single-pathogen vaccines (Malfertheiner et al., 2018). PRRS vaccines serve as a critical tool for managing this disease, illustrating the importance of multi-pathogen vaccine strategies in animal health. Continued efforts to improve vaccine efficacy and broaden immune protection across viral variants will enhance disease control in swine herds globally. 7 Strategies to Enhance Safety and Efficacy 7.1 Incorporation of adjuvants to enhance immune responses Adjuvants are substances added to vaccines to improve the strength, quality, and duration of the immune response. The use of adjuvants is especially important in multi-pathogen vaccines, where stimulating an effective immune response against multiple antigens simultaneously can be challenging (Facciolà et al., 2022). Adjuvants like aluminum salts (alum), oil-in-water emulsions (MF59), and newer adjuvant systems such as AS03 and CpG 1018 have been shown to significantly enhance the immunogenicity of vaccines by promoting stronger T-cell and antibody responses (Malfertheiner et al., 2018). For example, the use of the AS03 adjuvant in the H1N1 influenza vaccine not only increased antibody titers but also improved cross-reactivity with different strains of the virus, offering broader protection. Similar adjuvants are being explored in multi-pathogen vaccines to enhance immune responses while ensuring balanced protection against all pathogens included in the formulation (Heath et al., 2021). 7.2 Optimized vaccine dosing regimens Vaccine dosing regimens play a crucial role in determining both the efficacy and safety of multi-pathogen vaccines. Optimizing the number of doses and the intervals between them can significantly enhance immune responses and provide long-term protection. Multi-dose regimens often allow the immune system to develop a stronger and more sustained response, as seen with vaccines like the hepatitis B and HPV vaccines, which use a three-dose schedule to maximize immunogenicity (Elizaga et al., 2018). In multi-pathogen vaccines, carefully spaced doses ensure that the immune system has time to respond to each antigen without becoming overwhelmed. Research into COVID-19 vaccines has shown that a second or even third booster dose can significantly increase the production of neutralizing antibodies and improve long-term immunity, making it a key consideration for other multi-pathogen vaccines as well (Voysey et al., 2020). 7.3 Development of delivery systems Innovative delivery systems are critical to enhancing the safety and efficacy of multi-pathogen vaccines. These systems are designed to ensure that the vaccine components reach the correct immune cells efficiently and generate a potent immune response. Nanoparticle-based delivery systems, liposomes, and viral vectors are examples of cutting-edge technologies that can improve the stability, targeting, and release profiles of multi-pathogen vaccines. Nanoparticle delivery systems, for instance, encapsulate antigens in a protective shell that improves their stability and promotes their uptake by antigen-presenting cells (APCs). These systems can also release antigens slowly over time, providing a sustained immune stimulus. Viral vectors, like those used in the COVID-19 vaccines, are engineered to deliver genetic material encoding multiple pathogen antigens directly to the host cells, ensuring a strong and localized immune response (Folegatti et al., 2020). These advancements in delivery technology allow for more precise immune responses, greater vaccine stability, and the potential for single-dose formulations, which would simplify vaccine administration and improve coverage.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==